NEW YORK (GenomeWeb News) - Clinical Data's share price climbed 8 percent to $39 a share in late-morning trading today, reaching a new 52-week high.
 
Earlier this month, the company authorized a 3-for-2 stock split for shareholders of record as of Sept. 24. The new shares will be distributed Oct. 1.
 
Clinical Data’s shares are up more than 12 percent for the week beginning Sept. 24.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.